Law
Offices of Howard G. Smith announces an investigation on behalf of
investors of MannKind Corp. (“MannKind” or the “Company”) (NASDAQ: MNKD)
concerning the Company and its officers’ possible violations of federal
securities laws. Injured investors are encouraged to contact the Law
Offices of Howard G. Smith to discuss their legal rights.
Specifically, the investigation concerns whether or not MannKind misled
investors and inflated its stock price by failing to disclose that the
mandated pulmonary testing of one of its leading products Afrezza,
remained a significant issue impeding current and future sales of
Afrezza, the Company’s rapid-acting insulin. On news of the declining
sales of Afrezza, and the Company’s plan to restate its prior financial
statements, the Company’s shares fell dramatically, thereby damaging
MannKind investors.
If you purchased MannKind securities, have information or would like to
learn more about these claims, or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160302005494/en/
Copyright Business Wire 2016